BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Clinical trials in Russia and Azerbaijan demonstrated safety of AstraZeneca and Sputnik Light vaccines combination

  The Russian Direct Investment Fund announce interim results of phase II clinical trials to evaluate the safety and immunogenicity of the combined use of AstraZeneca’s vaccine and the first component of the Sputnik V coronavirus vaccine (Sputnik Lite).

  February 14, 2022

   · 

  3 min read
• Invitation to presentation of Isofol’s year-end report 2021 on February 24, 2022

  Isofol Medical AB, will publish the company’s year-end report 2021 on Thursday, February 24, 2022.

  February 14, 2022

   · 

  2 min read
• Shanghai Public Health Clinical Center Initiated Functional Cure Study of Anti-PD-L1 Antibody ASC22 (Envafolimab) in Combination With Chidamide in HIV-Infected Patients

  Ascletis Pharma Inc. announces that Shanghai Public Health Clinical Center initiated functional cure study of anti-PD-L1 antibody ASC22 in combination with Chidamide in patients infected by human immunodeficiency virus with antiviral suppression.

  February 14, 2022

   · 

  4 min read
• Opthea Data for OPT-302 in Patients with Polypoidal Choroidal Vasculopathy (PCV) Presented at Angiogenesis 2022

  Opthea Limited, a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced data was presented at the Bascom Palmer 19th annual Angiogenesis, Exudation, and Degeneration 2022 Conference.

  February 14, 2022

   · 

  6 min read
• Clover Provides Corporate Update and 2022 Priorities

  Clover announces universal COVID-19 vaccine booster development plan to support global use of its COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum).

  February 14, 2022

   · 

  13 min read
• Business

  FibroGen to Report Fourth Quarter and Full Year 2021 Financial Results

  FibroGen, Inc. (NASDAQ: FGEN) will announce its fourth quarter and full year 2021 financial results on Monday, February 28 after the market close.

  February 14, 2022

   · 

  1 min read
• BioMidwest

  Myriad Genetics to Present at Two Upcoming Healthcare Conferences

  On Feb. 17, 2022, R. Bryan Riggsbee, chief financial officer, will participate in a fireside chat at the virtual BTIG MedTech, Digital Health, Life Sciences & Diagnostic Tools Conference at 12 p.m. ET.

  February 14, 2022

   · 

  1 min read
• Business

  AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2021

  Applied Genetic Technologies Corporation today announced financial results for the quarter ended December 31, 2021.

  February 14, 2022

   · 

  15 min read
• Business

  Avadel Pharmaceuticals Appoints Dr. Douglas Williamson as Chief Medical Officer

  Avadel Pharmaceuticals plc today announced the appointment of Douglas Williamson, MBChB, as Chief Medical Officer.

  February 14, 2022

   · 

  5 min read
• BioMidwest

  UAT Group Subsidiary, Ossifix Orthopedics, Begins Production of Fixation Pin, Significant Sales Expected

  Umbra Applied Technologies Group, Inc, announced that it has begun fulfilling purchase orders and contracts for orthopedic distributors and clients nationwide.

  February 14, 2022

   · 

  4 min read